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Is Left Ventricular Longitudinal Function a Determinant of Plasma
Brain Natriuretic Peptide during Exercise in Patients with Organic
Mitral Regurgitation?
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Lancellotti
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Introduction: Plasma brain natriuretic peptide (BNP) may be used for risk
stratification in patients with organic mitral regurgitation (OMR). Whether
exercise can induce changes in BNP in patients with OMR has never been
investigated.
Method and results: Resting and exercise transthoracic echocardiography
including Doppler, tissue Doppler imaging (TDI) and 2-D speckle-tracking
(2DSt) quantification were performed in 56 consecutive patients (61±15 yrs,
54% of male) with moderate to severe OMR. Peak velocity and time-to-peak
velocity (TP) were measured using TDI for Ea-, Aa- and Sa-wave. 2DSt was
use to evaluate global LV longitudinal strain (GLS). Blood samples were drawn
at rest and 5 min after peak exercise to measure plasma BNP level. BNP
increases during exercise (from 27±18 to 35±24pg/ml, p<0.001) and peak exer-
cise BNP was correlated to exercise LV ejection fraction (EF) (r=-0.36,
p=0.007) and to exercise Sa velocity (r=-0.41, p<0.001), TP-Sa (r=0.32,
p=0.02) and TP-Ea (r=0.39, p=0.004). The best correlation with peak BNP was
found with peak GLS (r=-0.58, p<0.0001). In addition, there were significant
associations between the changes in BNP and the changes in LVEF (r=-0.35,
p=0.009), Sa velocity (r=-0.37, p=0.005), TP-Ea (r=0.35, p=0.01), and GLS
(r=-0.44, p=0.0001). On multivariate analysis, after adjustment for age, sex and
LVEF, only peak GLS and TP-Ea were independently associated with peak
BNP (r2=0.34, p<0.0001 and r2=0.11, p=0.003, respectively). Furthermore, only
changes in Sa velocity (r2=0.23, p=0.0004) and in GLS (r2=0.17, p=0.03) were
independently associated, after adjustment, with the changes in BNP.
Conclusion: Exercise and exercise-induced changes in LV longitudinal
function are the major determinants of both exercise and changes in BNP
during exercise, in patients with OMR. These results suggest that LV longitu-
dinal function should be systematically quantified during stress echocardio-
graphy to detect latent subclinical LV dysfunction.
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Changes in Systolic Pulmonary Arterial Pressure during Exercise are
Related to Changes in Mitral Regurgitation
Julien Magne, Marie Moonen, Kim O’Connor, Luc A. Piérard, Patrizio
Lancellotti
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Introduction: Current guidelines recommend mitral surgery for asymp-
tomatic patients with severe organic mitral regurgitation (OMR) and preserved
LV systolic function when exercise pulmonary hypertension (PHT) is present.
However, the determinants of exercise-induced PHT in such patients have not
been evaluated.
Method and results: Resting and exercise transthoracic echocardiography
were performed in 66 consecutive patients (61±15 years, 55% of male) with
significant OMR. MR severity evaluated using effective regurgitant orifice
(ERO) area. Systolic pulmonary arterial pressure (PAP) was derived from tri-
cuspid regurgitation peak velocity and exercise PHT was defined as transtri-
cuspid pressure gradient ≥50mmHg. Compared to patients with exercise
PAP <50mmHg, those with exercise PHT (n=28, 42%) were significantly
older. There was no significant difference between the 2 groups with regard to
resting and exercise LV functions and to resting ERO. Nonetheless, patients
with exercise PHT had higher exercise ERO (50±22 vs. 38±14mm2, p=0.03).
The changes in ERO during exercise were significantly higher in patients with
PHT (8±12 vs. -2±12mm2, p=0.004). Regarding to peak exercise PAP, the best
correlations were found with age (r=0.39, p=0.007) and exercise ERO (r=0.47,
p=0.0009). Moreover, changes in PAP during exercise were only correlated
with the changes in ERO (r=0.50, p=0.0012). On multivariate analysis, after
adjustment for age, sex and resting PAP, exercise-induced changes in ERO
were independently associated with the changes in PAP (ERO: β=0.4,
p=0.002). In addition, changes in MR severity were also independent predic-
tors of exercise PHT (ERO: odds-ratio (OR) =1.2, 95%CI: 1.1-1.4, p=0.0008).
Conclusion: Exercise PHT is frequent in patients with OMR. Changes in
MR severity during exercise are the main determinants of exercise-induced
changes in systolic PAP. Further studies are needed to evaluate whether
changes in MR severity during exercise may have a prognostic impact in
patients with OMR.
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Infective endocarditis and bicuspid aortic valve: charactéristics and 1
year outcome
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Background: Bicuspid aortic valve is a common malformation which may
de complicated by infective endocarditis (IE). Nethertheless, profile and out-
come of infective endocarditis on bicuspid aortic valve is undefined.
Objectives: To determine clinical and paraclinical characteristics of infec-
tive endocarditis on bicuspid aortic valve, and its outcome at 1 year.
Methods: Bicentric cohort study of 310 IE involved native aortic valves,
presenting to Amiens’s and Marseille’s Hospitals from January 1991 through
May 2007.
Results: Bicuspid aortic valve were found in 50 patients(16,2%), mean age
45±16 years(p=0,0001),sex ratio 5,25/1. Charlson’s comorbidity index was
lower in bicuspid valve (1,64±2,56 vs 2,78±2,43; p=0,003). Abscesses was
detected in 50% of cases of bicuspid valve vs 19,7% on tricuspid aortic valve
(p=0,0001). Previous antibiotic therapy before diagnosis was more frequent in
bicuspid IE (30,4 vs 13,7%,p=0,005), as well as negative blood cultures(24 vs
10%,p=0.006). Digestive organisms were significantly less isolated in bicuspid
valve. Rate of embolic events was not different.
In bicuspid valve IE, surgery was performed in 72% of cases. Peri-opera-
tive mortality was 11.1%, Staphylococcus aureus infection was the only inde-
pendent predictor of peri-operative mortality (HR 34,9; IC95% 1,5-
76,8;p=0,024). Uncontrolled infection was the independent predictor of 1 year
mortality(HR 20,55 ;IC95% 1,5-268;p=0,021). One year survival of bicuspid
valve endocarditis tended to be better compared with that of tricuspid
aortic valve(87% vs 77%,p=0,14), but this trend was corrected by age-
match(HR 0,656;IC95% 0,38-2,35;p=0,33).
Conclusions: Endocarditis of bicuspid aortic valve is frequent in native
aortic valve IE, is associated with a younger age, with more annular aortic
abscesses, and more use of previous antibiotic therapy before diagnosis. One-
year prognosis seems to be no different from tricuspid aortic valve after age-
adjustment
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Increased cardiac troponin is observed after valvular surgery, indicating
perioperative myocardial injury, although the clinical significance of this
elevation remains controversial. The current study was designed to evaluate
the frequency of troponin elevation and the degree of myocardial injury after
transcutaneous aortic valve replacement (TAVR), a new procedure for the
treatment of high surgical risk patients (pts) with degenerative aortic stenosis
(AS).
Methods: 51 consecutive pts (84±6 years old) with severe symptomatic AS
and a high surgical risk for valve replacement had retrograde TAVR using the
Edwards-Sapien balloon expandable heart valve. 27% of pts had previous cor-
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onary artery bypass graft and 25 % had previous coronary angioplasty. At the
time of valve implantation, 35 % of pts had at least one significant coronary
stenosis (> 50 %). TAVR was performed under local anesthesia after surgical
cut-down of the femoral artery. A 23 or 26 mm transcutaneous valve was
implanted during a brief period of rapid pacing (200 to 220 bpm). Cardiac
Troponin I was measured using the DPC Immulite 2500 assay (lower limit of
detection: 0.2 μg/l, suggested diagnostic value for myocardial infarction: 1.0
μg/l) before, 8 hours and 24 hours after TAVR.
Results: After TAVR, the effective orifice area increased from 0.64 ± 0.14
to 1.80 ± 0.3 cm2 (p< 0.0001) and the transvalvular mean gradient decreased
from 47 ± 15 to 8 ± 4 mmHg (p<0.0001). Troponin level was 0.07 ± 0.15 μg/
l at baseline and significantly increased 8 hours (2.57 ± 2.47 μg/l) and 24
hours (4.82 ± 8.02 μg/l) after TAVR (p<0.001). Troponin level was above 1.0
μg/l in 45 (88%) pts. No pts exhibited new pathological Q-waves.
Conclusions: Moderate elevations in troponin are common after TAVR.
These data should help to define the level of troponin elevation indicating
periprocedural myocardial infarction. Whether increase in troponin level after
TAVR has a prognostic impact remains to be determined in a larger population.
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are the Main Determinants of Aerobic Capacity in Mitral Stenosis
Guillaume Deswarte (1), Sébastien Pouwels (1), Béatrice Cavestri (2), Anne
Sophie Polge (1), Pierre Vladimir Ennezat (1), Thierry Perez (2), Ghislaine
Deklunder (1), Benoît Wallaert (2), Thierry Le Tourneau (1)
(1) Cardiology University Hospital, Lille, France – (2) Respiratory
Diseases University Hospital, Lille, France
Purpose: There is a paucity of data regarding consequences of mitral
stenosis (MS) on respiratory function and exercise capacity. In view of fre-
quent discrepancies between symptoms and anatomy in MS, identification of
determinants of aerobic capacity could be useful in the clinical-decision
making process. Our objective was to evaluate the role of cardiac and pulmo-
nary alterations on aerobic capacity in MS.
Methods: Twenty-eight patients (53±7 y) with history of MS were pro-
spectively included. A comprehensive echocardiography was performed at rest
and during exercise. Right ventricular (RV) systolic function was assessed
with tricuspid lateral annulus S wave velocity (STric). Respiratory function
was assessed at rest with measure of transfer of carbon monoxide (DLCO).
We analyzed the two components of DLCO: membrane diffusion (DM) and
capillary volume (VCAP). Maximal oxygen uptake (VO2max) was determined
during cardio-pulmonary exercise test.
Results: Ten patients were examined before (native MS group) and 18
after corrective treatment (treated MS group). The mitral valve functional area
(MVA) was 1.3±0.3 cm2 in native MS group and 1.6±0.1 cm2 in treated MS
group. Overall, NYHA class was 1.8±0.3, VO2max 18±3 ml/kg/min, maximal
workload 85±13 Watts. There were no differences between groups in NYHA
class, maximal workload, VO2max, trans-mitral and trans-tricuspid gradients
and DLCO. DM and VCAP were impaired in patients with a history of MS.
In univariate analysis determinants of VO2max were gender (r=0.6, p=0.001),
DM (r=0.65, p=0.04), VCAP (r=0.69, p=0.001), exercise cardiac output
(r=0.55, p=0.003), and exercise STric (r=0.56, p=0.008). In multivariate anal-
ysis, independent determinants of VO2max were exercice STric (r=0.55,
p=0.005) and VCAP (r=0.46, p=0.01).
Conclusion: DM and VCAP are impaired in MS. RV contractile reserve
and VCAP are the main determinants of aerobic capacity in MS. Theses
parameters could be used in the clinical-decision making process in MS.
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Background: Prosthetic valve endocarditis (PVE) is a rare and serious
complication after heart valve replacement. Despite progress in therapeutic
modalities, morbidity and mortality remain untolerably high.
Objective: to evaluate the current outcome of PVE in a high volume ter-
tiary care center in Tunisia and to analyse predictors of mortality.
Methods: All cases of PVE treated in our institution between 1997 and
2008 were analysed according to the modified DUKE criteria. Univariate and
multivariate analysis were performed to assess predictors of mortality. Two
sided p values<0.05 were considered significant.
Results: During the study period, 234 IE were diagnosed, among them
74 were PVE (42 males and 32 females), mean age was 39.23 years. They
were early PVE in 38 cases (51.4%) and late PVE in 36 cases (48.6%).
28 patients (38.7%) underwent surgical intervention during the active
phase. 14 patients died during index hospitalization (i.e. 18.9% in hospital
mortality).
In comparison with survivors, patients who died had a considerably longer
delay to diagnosis (18.9 days vs 8.89; p=0.03), more hyperleucocytosis (14678
vs 10234; p=0.015) and more severe anemia (8.56 g/dl vs 10.46g/dl). They
suffered considerably more congestive heart failure (78.6% vs 10%; p<0.001)
and were more likely to undergo surgery during the active phase (71% vs
30%; p=0.006).
Echocardiographically, patients who died presented more frequently highly
mobile vegetations (63.8% vs 17.8%; p=0.005), massive vegetations (>15mm)
(44.4% vs 4.2%; p=0.013), annular abscess (38.5% vs 1.7%; p<0.001), pros-
thetic dehiscence (42.9%vs 17.3%;p=0.049) and prosthetic abscesses (28.6%
vs 3.8%;p<0.001).
Conversely, neither age nor causative organisms were associated with in
hospital mortality.
On multivariate analysis, the only variable strongly correlated with in hos-
pital death was congestive heart failure (HR=27.5, p=0.005, 95% CI [2.78-
276.6]).
Conclusion: PVE remains very serious condition carrying high mortality
rates.In our series, the strongest predictor of mortality was congestive heart
failure.
180
Dramatic Reduction of Infective Endocarditis-Related Mortality
Associated with a Management-Based Approach
Franck Thuny (1), Elisabeth Botelho-Nevers (2), Jean-Paul Casalta (2),
Hervé Richet (2), Frédérique Gouriet (2), Jean-François Avierinos (1),
Frédéric Collart (3), Alberto Riberi (3), Gilbert Habib (1), Didier Raoult
(2)
(1) Hopital la Timone, Département de cardiologie, 13005, France – (2)
Hôpital de la Timone, Microbiologie, Marseille, France – (3) Hôpital de
la Timone, Service de chirurgie cardiaque, Marseille, France
Background: Despite improvements in medical and surgical therapy,
infective endocarditis (IE) is still associated with a severe prognosis and
remains a therapeutic challenge. We aimed to evaluate the impact of a stan-
dardized diagnostic and therapeutic protocol on mortality and to correlate the
outcome with the compliance to our management-based protocol.
Methods: Observational before-after study including 333 consecutive
patients treated for IE at a referral center conducted from 1991 to 2006 and
divided in two periods: period 1 (1991 to 2001), before implementation of
our therapeutic protocol (n=173) and period 2 (2002 to 2006) after imple-
mentation of our protocol (n=160) created by a multidisciplinary task force
including a sampling of biological specimens, the use of only four antimi-
crobials, a standardized duration of treatment, standardized surgical indica-
tions, and one year follow-up. Because our protocol was based on a local
consensus by physicians and surgeons, it was impossible to randomize the
study.
Results: The one-year mortality significantly decreased from 18.5% during
period 1 to 8.2% during period 2 (hazard ratio=0.41; 95% confidence interval,
